Anthony M. DiGiorgio

Jul 26, 2024 | pacificresearch.org | Anthony M. DiGiorgio

By Anthony M. DiGiorgio, DO, MHA and Wayne Winegarden, PhDEnacted by the US Congress in 1992 to help entities serving lower-income and uninsured patients stretch their resources, the 340B Drug Pricing Program mandated drug companies give large discounts to covered entities (CEs). Judging the program on its outcomes, not its intentions, there is growing evidence that the 340B program fails to achieve its primary goal.

Jul 26, 2024 | jamanetwork.com | Anthony M. DiGiorgio |Wayne Winegarden

Enacted by the US Congress in 1992 to help entities serving lower-income and uninsured patients stretch their resources, the 340B Drug Pricing Program mandated drug companies give large discounts to covered entities (CEs). Judging the program on its outcomes, not its intentions, there is growing evidence that the 340B program fails to achieve its primary goal.

Jan 6, 2024 | ocregister.com | Anthony M. DiGiorgio |Anil N. Makam

Beginning in January, the nation’s most populous state will put to the test the idea that Medicaid is reserved for the needy, as determined by income and asset thresholds reflecting our earnings and wealth. It may create a burden that robs America’s poor to pay rich Californians. As a partly federally funded, state-run form of health insurance, Medicaid is in many respects 50 unique programs.